In 2015, the Food and Drug Administration (FDA) approved Addyi (flibanserin), a prescription medicine heralded as a long overdue “female Viagra.” It also slapped a black box warning
on the package to call attention to side effects of the drug considered serious or life-threatening.
Chief among them: women who took the drug while drinking alcohol ran the risk of losing consciousness.
Recently, Addyi’s manufacturer, Sprout Pharmaceuticals, announced results of some new research in hopes of getting that concerning warning removed.
“The additional insights provided by these three new studies are invaluable for a more comprehensive understanding of Addyi for safe use,” said Cindy Eckert, founder and CEO of Sprout Pharmaceuticals, in a press release. “This additional data contextualizes and further clarifies the relationship between Addyi and alcohol.”
Yet some experts aren’t convinced it proves the drug is safe to take with alcohol — and neither is theFood and Drug Administration (FDA).
source https://www.healthline.com
No comments:
Post a Comment